TOKYO -- Japan's Mitsubishi Chemical Group has granted a first-refusal right to U.S. investment fund Bain Capital for the purchase of its pharmaceutical subsidiary Mitsubishi Tanabe Pharma, Nikkei has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback